Approximately 9 years of experience as a researcher in quantitative analyses carried out with different imaging modalities, with the aim of identifying disease or worsening of disease at an early stage in order to improve treatment and patient prognosis.
In recent years, the focus has also been biomarkers in the blood, including genetic risk markers and disease-specific markers, aimed for early detection of disease or disease activity.
